Last checked at 7 Jul 2010 11:49
| For immediate release | 7 July 2010 |
Futura Medical plc
("Futura" or "the Company")
Grant of Options
Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, announces that on 6th July 2010 it granted options over a total of 650,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.
| Director | Number of options granted | Exercise price | Exercise period | Total number of options held following notification | Total number of ordinary shares held |
|
|
|
|
|
|
|
| W D Potter | 100,000 | 40.50p | 1 Aug 2012 - 31 Jul 2017 | 200,000 | 131,098 |
| J H Barder | 250,000 | 40.50p | 1 Aug 2012 - 31 Jul 2017 | 450,000 | 745,212 |
| D B Davies | 200,000 | 40.50p | 1 Aug 2012 - 31 Jul 2017 | 400,000 | 532,572 |
| D A Martin | 100,000 | 40.50p | 1 Aug 2012 - 31 Jul 2017 | 500,000 | 125,000 |
All options were granted under the Futura Medical plc Unapproved Share Option Scheme with the exception of 176,543 options granted to each of J H Barder and D B Davies which were granted under the Futura Medical plc Enterprise Management Incentive Scheme.
The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.
For any further information please contact:
| Futura Medical plc |
|
| James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
|
|
|
| mail to: james.barder@futuramedical.com | www.futuramedical.com |
|
|
|
| Nomura Code Securities Limited |
|
| Phil Walker / Giles Balleny | Tel:+44 (0)20 7776 1200 |
|
|
|
| For media enquiries please contact: |
|
|
|
|
| Buchanan Communications |
|
| Mark Court / Stasa Filiplic / George Prassas | Tel: +44 (0) 20 7466 5000 |
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com